Home

Scott R. Ward

CIK 1174531 · Chairman and CEO · last filed 2026-05-19

Scott R. Ward is a Chairman and CEO who has filed 82 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for MMSI, was dated May 19, 2026. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.5M across reported positions. 57 SEC filings were submitted jointly with MEDTRONIC INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.53M

Companies

6

Total Filings

82

Lifetime Open-Market Net

-$2.68M

Filer Profile

Reported Address
RAYMOND HOLDINGS, LLC
6410 BALLANTINE CT.
INVER GROVE HEIGHTS, MN 55077
Formerly Known As
WARD SCOTT R (2002–2014)
Related Filers
MEDTRONIC INC — 57 joint filings, latest 2010-05-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MMSI Director 3,457 $86.36 $298.5K $0 1 2026-05-19
NSPR Director 237,096 $0.79 $187.3K $102.6K 3 2026-05-08
Cardiovascular Systems Inc (CSII) Delisted Chairman and CEO 232,712 $20.00 $4.65M $159.3K 34 2023-04-27
SURMODICS INC (SRDX) Delisted Director 4,207 $42.98 $180.8K $0 6 2014-12-05
MAPP Director 0 $28.11 $0 $31.4K 7 2013-03-04
MDT SVP & Pres CardioVascular 99,410 $90.96 $9.04M -$2.97M 31 2010-05-04

Recent Filings

82 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-19 MMSI Grant (A) +3,457 $0 EDGAR
2026-05-08 NSPR Buy (P) +89,250 $102.6K EDGAR
2026-01-16 NSPR Grant (A) +88,053 $0 EDGAR
2025-01-10 NSPR Grant (A) +16,245 $0 EDGAR
2023-04-27 Cardiovascular Systems Inc (CSII) Delisted Disp (D) −811,022 -$16.22M EDGAR
2023-02-14 Cardiovascular Systems Inc (CSII) Delisted Mixed +3,584 -$29.4K EDGAR
2022-08-23 Cardiovascular Systems Inc (CSII) Delisted Disp (D) −77,028 $0 EDGAR
2022-08-16 Cardiovascular Systems Inc (CSII) Delisted Tax (F) −16,006 -$266.3K EDGAR
2022-08-09 Cardiovascular Systems Inc (CSII) Delisted Grant (A) +319,759 $0 EDGAR
2022-05-23 Cardiovascular Systems Inc (CSII) Delisted Buy (P) +3,000 $43.5K EDGAR
Showing 1–10 of 82
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.